Adjuvant S‐1 vs gemcitabine
Serious adverse events · people with resectable cholangiocarcinoma
1 finding from 1 review
- Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 70 participantsVery low